Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
about
Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptorsHLA-G Molecules in Autoimmune Diseases and InfectionsRole of CD8 T cell subsets in the pathogenesis of multiple sclerosisMultiple sclerosis as a vascular diseaseA polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosisA major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.HLA typing from RNA-Seq sequence readsA three-way parallel ICA approach to analyze links among genetics, brain structure and brain function.Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditionsTrophoblasts, invasion, and microRNA.Heparin increases HLA-G levels in primary antiphospholipid syndrome.Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray studyAmniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammationSoluble HLA-G: Are they clinically relevant?Increased HLA-E expression in white matter lesions in multiple sclerosis.Natural killer cells and their receptors in multiple sclerosis.Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells.Emerging topics and new perspectives on HLA-G.Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis.Involvement of kynurenines in Huntington's disease and stroke-induced brain damage.The deviated balance between regulatory T cell and Th17 in autoimmunity.The immunosuppressive molecule HLA-G and its clinical implications.Hormonal and gender-related immune changes in multiple sclerosis.Human Parthenogenetic Embryonic Stem Cell-Derived Neural Stem Cells Express HLA-G and Show Unique Resistance to NK Cell-Mediated Killing.Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis.Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation.Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis.Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu.SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review.Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis.Gene polymorphism and HLA-G expression in patients with childhood-onset systemic lupus erythematosus: A pilot study.Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System.Heterologous expression of mutated HLA-G1 reduces alloreactivity of human dermal fibroblasts.CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus.Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.HLA-G 2012 conference: the 15-year milestone update.HLA-G 14-bp polymorphism affects the age of onset in Type I Diabetes Mellitus.[Dissecting the pathways of tumour escape: " question of life and death?"].
P2860
Q24293562-87B5BF7D-336E-45A7-89D3-64931DAB5FF6Q26825516-A8377D1F-1450-46FF-9344-76E2E3B10FDBQ27010613-D49CB0E5-7717-4153-ABEB-C438521DD617Q28239335-774A7027-1616-49BD-8B8A-AA7273A46D07Q28748710-509DD139-B9FA-4764-9066-95FEDD4E22F4Q33622435-635DCD23-603F-4D16-9359-DC5400D7238DQ33781090-8F175A6B-5D32-4BCD-9047-8CBF954202DAQ34078309-FAE9B248-5C97-48E9-8472-F24D906877D8Q34093041-AB0ADD51-6C6E-42E5-BF66-B7249E5E38FEQ34390117-61A86CB2-5D2D-4FE8-87E9-C473884554F8Q35986350-24FC2A85-6BC2-42CA-A793-1491F66F9958Q36164195-A3BF5D3C-DA9B-467B-8675-B6BDAE69C271Q36179791-7A1EF915-5D1B-472D-A573-74CF417661C4Q36384011-5F56F7EE-5D60-417F-A6D1-B63B9D10C23EQ36488406-ADE39670-FB04-468A-A383-6CB105CA35E6Q37124504-7134FB40-1BAE-4DF1-A08F-77654A4956F4Q37445098-F221BCA4-050C-456A-8BA5-D666111C44BEQ37809764-7138FF55-9C68-4E8F-88EA-F55B6C7957A5Q37834024-83B92844-DB69-4559-856F-2644BD1026F1Q37892975-BB68D0D5-1F0A-4742-9D60-E136FE3CB8DBQ37982395-DE173036-16C8-41EC-AAD5-A0ADE198E2FDQ38005743-18E6E26A-A31A-4FB5-A7DE-3C1FB2523785Q38517191-38BF0E3A-4AD2-447D-BDFC-E7AB07E20DBBQ38894783-AA508863-7E43-458D-A48D-E10FA2A8067FQ40595918-00E731D4-0470-47D8-A848-BC463D51F328Q44327695-818CD0E9-79CA-4796-A3A1-BE355EBBF373Q44838586-8CCD6707-11D4-4EB0-BF59-DC563DECE569Q46396118-A559F2A0-3941-41BC-A5FD-D499D78D1195Q46923396-BA4D7A4C-5407-4A3D-AC73-3B05EB035B1AQ47920956-AE9D4AA7-811F-47EE-B26D-9CF79154A995Q48124202-F012ACBF-1A9F-4C80-BD1C-051097A6B174Q48146977-4983540E-FBC9-44D1-862A-D45FE1E5AC3BQ48266534-DD98057F-D5E6-4D22-8731-E53DBED21D8DQ50445163-430ED97D-F704-48B7-8279-62BD12769020Q50777705-BF7C29DF-8642-4C1A-A469-ECE805AD7106Q51752531-964F74A2-C7BF-497B-BD89-BAC8CA823A2CQ52577393-7CC5E11A-16D0-435A-99ED-2E2E2BE2A6D8Q53117151-39B28E84-3F0B-4845-A248-D22938242A90Q53121646-14ECF786-1FB1-44FE-9AAE-90BCFDA8F99CQ53320503-FA86AF91-296D-404D-9F45-46E2114611B1
P2860
Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Expression of the immune-toler ...... implications for CNS immunity.
@en
Expression of the immune-toler ...... implications for CNS immunity.
@nl
type
label
Expression of the immune-toler ...... implications for CNS immunity.
@en
Expression of the immune-toler ...... implications for CNS immunity.
@nl
prefLabel
Expression of the immune-toler ...... implications for CNS immunity.
@en
Expression of the immune-toler ...... implications for CNS immunity.
@nl
P2093
P2860
P50
P356
P1433
P1476
Expression of the immune-toler ...... implications for CNS immunity.
@en
P2093
Amit Bar-Or
Bettina Schreiner
Carolyn Jack
Christine Stadelmann
Jack Antel
Wolfgang Brueck
P2860
P304
P356
10.1093/BRAIN/AWH609
P407
P577
2005-08-25T00:00:00Z